• Blog
  • Drug Discovery Informatics Market Growth Analysis | 2022-2028

    Drug Discovery Informatics Market Growth Analysis | 2022-2028

    Drug Discovery Informatics Market Growth Analysis | 2022-2028
    Report code - SRHL168 Delivery - 2 Weeks
    Drug Discovery Informatics Market Size, Share, Trends, Forecast, & Growth Analysis -&n See more...

    Market Insights

    The drug discovery informatics market was estimated at USD 2.32 billion in 2021 and is likely to grow at a CAGR of 9.23% during 2022-2028 to reach USD 4.35 billion in 2028.

    Drug-Discovery-Informatics-Market-Insights

    Want to know more about the market scope? Register Here

    What is drug discovery informatics?

    Drug discovery informatics encompasses the creation of systems that can work more capably with large sets of clinical trial and treatment data. Discovery and development of drugs is a highly complex process, requiring the creation of large amounts of data and information.

    Drug Discovery Informatics Market Report Overview

    Market Size in 2028

    USD 4.35 Billion

    Market Size in 2021

    USD 2.32 Billion

    Market Growth (2022-2028)

    CAGR of 9.23%

    Base Year of Study

    2021

    Trend Period

    2016-2020

    Forecast Period

    2022-2028

    Key Players

    Some of the major players in the drug discovery informatics market are-

    • Accenture PLC
    • Albany Molecular Research Inc.
    • Charles River Laboratories International, Inc.
    • Clarivate Analytics LLC
    • Eurofins Scientific SE
    • IBM Corporation
    • Jubilant Life Sciences Limited
    • PerkinElmer Inc.
    • Schrödinger, Inc.
    • Thermo Fisher Scientific Inc.

    Market Dynamics

    The prime factors that are likely to drive the market are the increasing expenditure in R&D activities, growing support for research in the pharmaceutical areas, especially for rare diseases, and the escalating use of informatics for discovery of new drugs.

    Drug-Discovery-Informatics-Market-Dynamics

    Want to have a closer look at this market report? Click Here

    Segments Analysis

    By Function Type

    The market is segmented as sequencing & target data analysis, docking, molecular modeling, library & database preparation, and others. The sequencing & target data analysis segment held the largest share of the market in 2021, owing to the increased application of sequencing analysis and ease of handling information from different sources and domains. The segment is likely to maintain its leading position during the forecast period as well.

    By End-User Type

    The drug discovery informatics market is segmented as pharmaceutical companies, biotechnology companies, contract research organizations (CROs), and others. The pharmaceutical companies segment led the market in 2021 and is expected to dominate the market over the forecast period. The growth of the segment is driven by the extensive use of software for pre-clinical research & developmental activities, target identification, compound screening and lead identification, and streamlining drug discovery processes.

    Regional Insights

    North America held the largest share of the market in 2021, followed by Europe. North America is expected to command the market during the forecast period as well. The dominant position of North America is due to the presence of major CROs and increasing expenditure by pharmaceutical and biopharmaceutical companies. On the other hand, Asia-Pacific is likely to grow at the highest CAGR during the forecast period, driven by the rapid growth of pharmaceutical and biopharmaceutical industries and a growing number of CROs in the region, with China and India being the major countries offering promising growth opportunities over the forecast period.

    Drug-Discovery-Informatics-Market-Regional-Insights

    Know the high-growth countries in this report. Register Here

    Critical Questions Answered in the Report

    • What are the key trends in the global market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global market?
    • What are the key strategies adopted by the major vendors to lead in the market?
    • What is the market share of the top vendors?

    Market Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The drug discovery informatics market is segmented into the following categories:

    By Function Type

    • Sequencing & Target Data Analysis
    • Docking
    • Molecular Modelling
    • Library & Database Preparation
    • Others

    By Application Type

    • Drug Discovery
    • Drug Development
      • (Application Type Analysis: Preclinical Testing and Clinical Trials)

    By Solution Type

    • Software
    • Services

    By End-User Type

    • Pharmaceutical Companies
    • Biotechnology Companies
    • Contract Research Organizations (CROs)
    • Others

    By Region

    • North America (Country Analysis: the USA, Canada, and Mexico)
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Drug-Discovery-Informatics-Market-Segmentation

    Click Here, to learn the market segmentation details.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Drug Discovery Informatics Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation of any one of the solution types by end-user type.

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Drug discovery informatics encompasses the creation of systems that can work more capably with large sets of clinical trial and treatment data. Discovery and development of drugs is a highly complex process, requiring the creation of large amount of data and information.

    The drug discovery informatics market was estimated at USD 2.32 billion in 2021.

    The drug discovery informatics market is likely to reach USD 4.35 billion in 2028.

    The drug discovery informatics market is likely to grow at a CAGR of 9.23% during 2022-2028.

    North America is expected to remain the largest market for drug discovery informatics during the next five years.

    Accenture PLC, Albany Molecular Research Inc., Charles River Laboratories International, Inc., Clarivate Analytics LLC, Eurofins Scientific SE, IBM Corporation, Jubilant Life Sciences Limited, PerkinElmer Inc., Schrödinger, Inc., and Thermo Fisher Scientific Inc are among the key players in the market.

    The pharmaceutical companies’ segment is expected to remain the dominant end-user in the market in the coming years.

    The prime factors that are likely to drive the market are the increasing expenditure in R&D activities, growing support for research in the pharmaceutical areas, especially for rare diseases, and the escalating use of informatics for discovery of new drugs.